Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism 5T4 inhibitors(Trophoblast glycoprotein inhibitors), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC39H65N5O8 |
InChIKeyMFRNYXJJRJQHNW-DEMKXPNLSA-N |
CAS Registry745017-94-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Discovery | CN | 14 Feb 2023 |